Selegiline Hydrochloride is used for treating hypertension and heart failure. It was first introduced by Norvium Bioscience Llc in its drug Selegiline Hydrochloride on Jun 5, 1989. Other drugs containing Selegiline Hydrochloride are Eldepryl, Zelapar. 12 different companies have introduced drugs containing Selegiline Hydrochloride.

Selegiline Hydrochloride Patents

Given below is the list of patents protecting Selegiline Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Zelapar	US6423342	Process for the preparation of a solid pharmaceutical dosage form	Mar 01, 2016 (Expired)	Bausch
Zelapar	US5648093	Pharmaceutical and other dosage forms	Jul 15, 2014 (Expired)	Bausch

Add above patents to watchlist

Selegiline Hydrochloride's Family Patents

Full family tree

Selegiline Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Selegiline Hydrochloride. The first generic version for Selegiline Hydrochloride was by G And W Laboratories Inc and was approved on Aug 2, 1996. And the latest generic version is by Rising Pharma Holdings Inc and was approved on Apr 2, 2019.

Given below is the list of companies who have filed for Selegiline Hydrochloride generic, along with the locations of their manufacturing plants worldwide.